Elimination of endogenous aberrant kappa chain transcripts from sp2/0-derived hybridoma cells by specific ribozyme cleavage: utility in genetic therapy of HIV-1 infections.

Por Duan, L, Pomerantz, R J
Publicado em 1994

Efficient replication of human immunodeficiency virus type 1 requires a threshold level of Rev: potential implications for latency.

Por Pomerantz, R J, Seshamma, T, Trono, D
Publicado em 1992

Endogenous reverse transcription of human immunodeficiency virus type 1 in physiological microenviroments: an important stage for viral infection of nondividing cells.

Por Zhang, H, Dornadula, G, Pomerantz, R J
Publicado em 1996

Adenosine-deaminase-associated immunodeficiency. I. Differential sensitivities of lymphocyte subpopulations exposed to 2-deoxycoformycin in vivo.

Por Bagasra, O, Howeedy, A, Pomerantz, R J
Publicado em 1992

Evidence that a cell cycle regulator, E2F1, down-regulates transcriptional activity of the human immunodeficiency virus type 1 promoter.

Por Kundu, M, Srinivasan, A, Pomerantz, R J, Khalili, K
Publicado em 1995

Blocked early-stage latency in the peripheral blood cells of certain individuals infected with human immunodeficiency virus type 1.

Por Seshamma, T, Bagasra, O, Trono, D, Baltimore, D, Pomerantz, R J
Publicado em 1992

Increasing transduction efficiency of recombinant murine retrovirus vectors by initiation of endogenous reverse transcription: potential utility for genetic therapies.

Por Zhang, H, Duan, L X, Dornadula, G, Pomerantz, R J
Publicado em 1995

The long terminal repeat is not a major determinant of the cellular tropism of human immunodeficiency virus type 1.

Por Pomerantz, R J, Feinberg, M B, Andino, R, Baltimore, D
Publicado em 1991

CD14 is involved in control of human immunodeficiency virus type 1 expression in latently infected cells by lipopolysaccharide.

Por Bagasra, O, Wright, S D, Seshamma, T, Oakes, J W, Pomerantz, R J
Publicado em 1992

Nuclear preservation and cytoplasmic degradation of human immunodeficiency virus type 1 Rev protein.

Por Kubota, S, Duan, L, Furuta, R A, Hatanaka, M, Pomerantz, R J
Publicado em 1996

Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle.

Por Shaheen, F, Duan, L, Zhu, M, Bagasra, O, Pomerantz, R J
Publicado em 1996

TAR-independent replication of human immunodeficiency virus type 1 in glial cells.

Por Bagasra, O, Khalili, K, Seshamma, T, Taylor, J P, Pomerantz, R J
Publicado em 1992

Amphipathic domains in the C terminus of the transmembrane protein (gp41) permeabilize HIV-1 virions: a molecular mechanism underlying natural endogenous reverse transcription.

Por Zhang, H, Dornadula, G, Alur, P, Laughlin, M A, Pomerantz, R J
Publicado em 1996

Intravirion reverse transcripts in the peripheral blood plasma on human immunodeficiency virus type 1-infected individuals.

Por Zhang, H, Bagasra, O, Niikura, M, Poiesz, B J, Pomerantz, R J
Publicado em 1994

Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody.

Por Duan, L, Bagasra, O, Laughlin, M A, Oakes, J W, Pomerantz, R J
Publicado em 1994

Kinetic analysis of intravirion reverse transcription in the blood plasma of human immunodeficiency virus type 1-infected individuals: direct assessment of resistance to reverse tr...

Por Zhang, H, Dornadula, G, Wu, Y, Havlir, D, Richman, D D, Pomerantz, R J
Publicado em 1996

Binding of intracellular anti-Rev single chain variable fragments to different epitopes of human immunodeficiency virus type 1 rev: variations in viral inhibition.

Por Wu, Y, Duan, L, Zhu, M, Hu, B, Kubota, S, Bagasra, O, Pomerantz, R J
Publicado em 1996

The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replication.

Por Duan, L, Ozaki, I, Oakes, J W, Taylor, J P, Khalili, K, Pomerantz, R J
Publicado em 1994

Central nervous system-derived cells express a kappa B-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent tra...

Por Taylor, J P, Pomerantz, R J, Raj, G V, Kashanchi, F, Brady, J N, Amini, S, Khalili, K
Publicado em 1994

Intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle by targeting human immunodeficiency virus type 1 integrase.

Por Levy-Mintz, P, Duan, L, Zhang, H, Hu, B, Dornadula, G, Zhu, M, Kulkosky, J, Bizub-Bender, D, Skalka, A M, Pomerantz, R J
Publicado em 1996